Pfizer Seeks FDA Approval For Adult COVID-19 Boosters

The video discusses a booster study showing 96% protection against symptomatic COVID-19, even with the Delta variant. The booster is a 30 microgram dose given six months after the initial two-shot series. There is high demand for boosters, especially after emergency approval for certain age groups. Moderna and Johnson & Johnson have authorized boosters, with specific eligibility criteria. The FDA and CDC have approved mixing and matching boosters, but none are authorized for those under 18. The approval process for boosters is faster due to it being a tweak to existing emergency authorizations.

What new insight or understanding did you gain from this video?